Official call identifier: HORIZON-CL4-2026-04-DIGITAL-EMERGING-19
Objective of the call
This challenge-driven call aims to accelerate the adoption of generative AI (GenAI) in strategic industrial sectors: aerospace, pharmaceuticals/drug development or telecommunications networks.
It supports multi-stage competitions that move solutions from early-stage development (TRL 3) to demonstration (TRL 6), strengthening Europe’s competitiveness in AI-driven innovation.
Scope of activities
Projects are expected to:
Eligible applicants
- Innovative SMEs, startups and enterprises aiming to scale and strengthen competitiveness
- Public-sector organisations driving transformation and societal impact
- Research and academic institutions commercialising knowledge
- Non-profit organisations delivering purpose-driven innovation
- Organisations based in EU Member States, EFTA/EEA, or Associated Countries (described in General Annex A, General Annex B, General Annex C)
- Minimum 3 independent partners from 3 eligible countries
Specific consortium we are looking for:
-
Consortia including industry leaders from one targeted sector (aerospace, pharma/drug development or telecom)
-
Organisations capable of managing competitive open calls and FSTP schemes
-
SMEs and GenAI technology developers
Eligible costs
Eligible costs follow standard Horizon Europe Research and Innovation Action (RIA) rules and include:
Funding conditions
Type of action:
Research and Innovation Action (RIA)
Funding rate:
100% of eligible costs
EU contribution per project:
Around EUR 15 million
Number of funded projects:
3 project
Project duration:
Typically 36 months
Technology Readiness Level (TRL):
Projects are expected to reach TRL 3–6 by the end of the project
*Technology Readiness Levels (TRL) describe the maturity of a technology, from basic research (TRL 1) to fully deployed, market-ready solutions (TRL 9).
Deadline for submission
15 April 2026